1 A review article of multiple randomized controlled trials reports an average weight loss of around 16% among users, with some losing as much as 17.4%
Available at: Assessed on June 18, 2021
If possible, continue your protocol with semaglutide from a verified source to avoid abrupt discontinuation
Some studies suggest that semaglutide helps protect mitochondria from damage while improving their efficiency, creating a cellular environment less prone to inflammatory responses
Overview of Clinical Trial Study 1 (NCT03574597) was a multi-national, multi-center, placebo-controlled, double-blind trial to determine the effect of WEGOVY relative to placebo on major adverse cardiovascular events (MACE) when added to current standard of care, which included management of CV risk factors and individualized healthy lifestyle counseling (including diet and physical activity)
If you have any questions about your specific dosing, please dont hesitate to reach out to our team at Good Hearts Health
